Doravirine
INDICATIONS
FDA
FDA
- Treatment of HIV in treatment-naive adult patients in combination with other ART
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 5, 2019
Citation
Smith, Janessa M. "Doravirine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540704/all/Doravirine.
Smith JM. Doravirine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540704/all/Doravirine. Accessed November 12, 2024.
Smith, J. M. (2019). Doravirine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540704/all/Doravirine
Smith JM. Doravirine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 November 12]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540704/all/Doravirine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Doravirine
ID - 540704
A1 - Smith,Janessa,PharmD, BCPS
Y1 - 2019/03/05/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540704/all/Doravirine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -